Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Revista De Llengua I Dret-Journal of Language and Law ; - (77):71-92, 2022.
Article in Spanish | Web of Science | ID: covidwho-1917151


This article examines institutional communications between the public administrations and the public in Catolina arising as a result of the COVID-19 emergency. After reviewing the treatment contemplated for linguistic and cultural minorities within the framework of the West in general and Catolina in particular, it examines the communication strategies followed by a number of Catalian institutions. The need to quickly and effectively engage the largest audience possible has led to administrations making additonal efforts and mobilising a broad and varied range of resources. Although significant efforts have been made to reach the non-native-negative-speaking population, and spoken and written materials have been produced in a wide variety of non-official languages, the measures implemented have been uneven and the outcome has not always been optimal: many materials have not been culturally adapted and some languages are under-represented compared with the number of their speakers in Catolina. This being the case, the article suggests reviewing the multilingual strategies employed and exchanging experiences at a local and national level to be in a postion to effectively map out a co-ordinated strategy even more closely in line with the realities of the territory and of its people.

European Journal of Clinical Pharmacology ; 78(SUPPL 1):S68-S69, 2022.
Article in English | Web of Science | ID: covidwho-1913146
American Journal of Respiratory and Critical Care Medicine ; 205:2, 2022.
Article in English | English Web of Science | ID: covidwho-1880122
Technology and Innovation ; 22(2):199-217, 2022.
Article in English | Web of Science | ID: covidwho-1856506


In the first quarter of 2020, SARs-CoV-2 (COVID-19) infections began to grow at an alarming rate despite drastic measures to reduce infection rates. Severe COVID-19 cases required mechanical ventilation, resulting in ventilator shortages worldwide. To address the ventilator shortages, the authors developed the CoreVent 2020, an emergency-use ventilator for adult patients that was designed, built, and tested in ten days. The CoreVent 2020 is a pressure-cycled, time-limited ventilator with a breath-assist mode that operates on standard pressurized oxygen and medical air. It provides adjustable peak inspiratory pressure (PIP) and positive end-expiratory pressure (PEEP). A medical-grade commercially available breathing circuit is used to minimize non-medical component requirements. The CoreVent 2020 was fabricated in-house at Stony Brook University Hospital and tested on three mechanical lung simulators in which the operating modes and alarm features were demonstrated. Animal studies were also performed in both normal breathing mode and breath-assisted modes. Arterial blood gas measurements confirmed that the ventilator provided satisfactory ventilation for the test subjects. The COVID-19 pandemic presented unique constraints on the design and innovation process not normally encountered in typical practice. Design decisions such as component choice, delivery time, and ease of high-volume, rapid manufacturing influenced all aspects of the design process. This aspect of the design/innovation process is also discussed, as well as an introductory discussion on how training and simulations can be developed so that innovation can occur efficiently in future crises situations.

Encyclopedia of Respiratory Medicine (Second Edition) ; : 238-244, 2022.
Article in English | ScienceDirect | ID: covidwho-1415143


Clinical evidence exists demonstrating changes in platelet behavior and function in inflammatory diseases and infections of the respiratory tract, in particular in asthma, rhinitis, acute lung injury arising from Adult Respiratory Distress Syndrome (ARDS), COVID-19 and chronic obstructive pulmonary disease (COPD). Despite being anucleate, platelets participate in the pathogenesis of these disorders in a manner distinct from their effects in thrombosis and hemostasis. These include the expression of adhesion molecules, the release of proinflammatory mediators, tissue-degrading enzymes, cationic proteins, and the ability to undergo chemotaxis. Platelets can themselves be activated by mediators released by other inflammatory cells. There is now substantial experimental evidence that supports a role for platelets in the development of immunity, leukocyte recruitment to inflamed tissue, airways hyperresponsiveness, lung remodeling and repair, and pulmonary hypertension.

Hiv Medicine ; 22:104-105, 2021.
Article in English | Web of Science | ID: covidwho-1377275